Home › Funds › Two Sigma Investments › NVCT
Two Sigma Investments position in NVCT
NUVECTIS PHARMA INC · Health Care
Latest position (Q3 2025)18.43K sh
Reported value held$110.98K
Portfolio Weight0.00%
First reportedQ4 2023
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 22.77K | $189.91K | New |
| Q2 2024 | 13.04K | $82.57K | New |
| Q3 2024 | 26.79K | $168.48K | Add |
| Q4 2024 | 18.57K | $100.46K | Reduce |
| Q1 2025 | 20.09K | $196.31K | Add |
| Q1 2025 | 20.09K | $196.31K | Add |
| Q2 2025 | 18.14K | $135.47K | Reduce |
| Q2 2025 | 18.14K | $135.47K | Reduce |
| Q3 2025 | 18.43K | $110.98K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding NVCT
- BlackRock Inc 1.00M sh · $18.41M · Q2 2026
- Geode Capital Management 432.27K sh · $7.95M · Q2 2026
- Vanguard Group 845.50K sh · $6.38M · Q4 2025
- Northern Trust Corp 146.71K sh · $2.70M · Q2 2026
- UBS Group AG 69.20K sh · $1.27M · Q2 2026
- Charles Schwab Investment Management 57.13K sh · $1.05M · Q2 2026
- BNY Mellon 36.77K sh · $676.19K · Q2 2026
- AQR Capital Management 31.89K sh · $586.38K · Q2 2026
- Goldman Sachs Group 20.48K sh · $376.63K · Q2 2026
- Morgan Stanley 18.72K sh · $344.28K · Q2 2026
- Deutsche Bank AG 16.87K sh · $310.31K · Q2 2026
- Citadel Advisors 15.70K sh · $288.72K · Q2 2026